The types of hepatobiliary cancers covered in these guidelines include hepatocellular carcinoma (HCC), gallbladder cancer, intrahepatic cholangio-carcinoma, and extrahepatic cholangiocarcinoma. By definition, these guidelines cannot incorporate all possible clinical variations and are not intended to replace good clinical judgment or individualization of treatments. Although not explicitly stated at every decision point of the guidelines, patient participation in prospective clinical trials is the preferred option for treatment of hepatobiliary cancers.
Screening
The purpose of a cancer screening test is to identify the presence of a specific cancer in an asymptomatic individual when early detection has the potential to favorably impact patient outcome. The panel supports the recommendation by the American Association for the Study of Liver Disease (AASLD) that HCC screening be “offered in the setting of a program or process in which screening tests and recall procedures have been standardized and in which quality control procedures are in place.”
Diagnosis of Hepatopancreaticobiliary cancer?
Some of the diagnosis of Hepatopancreaticobiliary cancer are here
- Imaging
- Biopsy
- Serum Biomarkers
- Pathology
- Staging
- Surgery
